| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 12 Feb 2025 | 18 Feb 2025 | 18 Feb 2025 | 1.5 | 75 | Interim 3 |
| Declared third interim dividend of Rs. 1.50/- (Rupees One and Paise fifty only) (75 %) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2024-25. The date for taking on record of its shareholders eligible for the purpose of payment of third interim dividend i.e., record date is fixed as Tuesday, the 18th February, 2025. The payment of said interim dividend will start from 28th February, 2025. | ||||||
| Dividend | 12 Nov 2024 | 27 Nov 2024 | 27 Nov 2024 | 1.5 | 75 | Interim 2 |
| Outcome of Board Meeting Declared second interim dividend of Rs.1.50 (Rupees one and fifty paise only) (75%) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2024-25. The date for taking on record of its shareholders eligible for the purpose of payment ofsecond interim dividend i.e., record date is fixed as Monday, the 25th day of November 2024. The payment of said interim dividend will start from 2nd December 2024. The Board of Directors vide circular Resolution dated November 13, 2024 have revised the Record Date as 27th November, 2024 for ascertaining the shareholders eligible for making payment of second Interim Dividend of Rs.1.50 (Rupee one and fifty paise only) which was declared by the Board of Director at their meeting held on November 12, 2024 The payment of said interim dividend will start from 4th December 2024 (As Per BSE Announcement dated on 13.11.2024) | ||||||
| Dividend | 12 Aug 2024 | 23 Aug 2024 | 23 Aug 2024 | 3 | 150 | Interim |
| Board Meeting Outcome for Outcome Of Board Meeting Declared interim dividend of Rs.3.00/- (Rupees Three Rupees only) (150%) each per equity share of Rs.2/- (Rupees two only) each for the financial year 2024-25. The date for taking on record of its shareholders eligible for the purpose of payment of interim dividend i.e., record date is fixed as Friday, the 23rd day of August, 2024. The payment of said interim dividend will start from 30th August, 2024. | ||||||
The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.
The company was ensured that the sale of the land and building did not constitute part of its operational assets so that the sale will, in no way, impact the company's business operations
The revenue for the September quarter rose by 33% to ₹1,371 crore from ₹1,031 crore in the corresponding period last year.
According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.
The plan to reduce the GST on these drugs aims to significantly reduce the overall cost of cancer treatment.
Natco Pharma disclosed that its subsidiary will invest USD 8 million in eGenesis, acquiring a total of 40,629,761 shares.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
